Alps Advisors Inc. Acquires New Position in Tenet Healthcare Corporation $THC

Alps Advisors Inc. bought a new position in Tenet Healthcare Corporation (NYSE:THC) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 2,360 shares of the company’s stock, valued at approximately $479,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of THC. Boston Partners raised its position in Tenet Healthcare by 95.0% during the 2nd quarter. Boston Partners now owns 2,267,142 shares of the company’s stock valued at $398,949,000 after purchasing an additional 1,104,500 shares in the last quarter. Ameriprise Financial Inc. increased its stake in shares of Tenet Healthcare by 8.0% during the second quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock valued at $373,020,000 after buying an additional 157,109 shares during the period. Norges Bank purchased a new stake in Tenet Healthcare in the second quarter worth about $206,981,000. AQR Capital Management LLC grew its holdings in Tenet Healthcare by 28.0% during the 2nd quarter. AQR Capital Management LLC now owns 1,156,263 shares of the company’s stock worth $200,224,000 after acquiring an additional 252,993 shares in the last quarter. Finally, Alliancebernstein L.P. increased its position in Tenet Healthcare by 375.7% during the 2nd quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock valued at $139,085,000 after purchasing an additional 624,125 shares during the period. Institutional investors own 95.44% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on THC. Barclays increased their price objective on shares of Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a research note on Friday. Morgan Stanley reaffirmed an “overweight” rating and set a $260.00 target price on shares of Tenet Healthcare in a research report on Thursday. Wells Fargo & Company reduced their price target on Tenet Healthcare from $252.00 to $229.00 and set an “overweight” rating for the company in a research report on Wednesday, January 7th. JPMorgan Chase & Co. raised their price objective on Tenet Healthcare from $200.00 to $230.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th. Finally, KeyCorp boosted their target price on shares of Tenet Healthcare from $225.00 to $250.00 and gave the stock an “overweight” rating in a report on Thursday. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Tenet Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $242.82.

Insider Activity at Tenet Healthcare

In related news, Director Nadja West sold 2,178 shares of the company’s stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the sale, the director owned 28,480 shares in the company, valued at $5,623,945.60. This represents a 7.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.81% of the stock is owned by company insiders.

Tenet Healthcare Trading Down 0.6%

NYSE THC opened at $230.90 on Friday. Tenet Healthcare Corporation has a 12-month low of $109.82 and a 12-month high of $235.77. The company has a fifty day simple moving average of $198.82 and a two-hundred day simple moving average of $194.69. The company has a current ratio of 1.76, a quick ratio of 1.64 and a debt-to-equity ratio of 2.18. The stock has a market cap of $20.29 billion, a P/E ratio of 14.91, a P/E/G ratio of 0.97 and a beta of 1.44.

Tenet Healthcare (NYSE:THC) last released its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The firm had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. During the same period in the prior year, the firm earned $3.44 EPS. The firm’s revenue was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, analysts forecast that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.